Telescope Innovations Installs Korea's First Self-Driving Lab for Pharma R&D and Education

Executive Summary

• Telescope Innovations successfully installed Korea’s first pharmaceutical Self‑Driving Lab (SDL) for the Korean Pharmaceutical and Biopharmaceutical Manufacturers Association (KPBMA) in Seoul, completing the project within three weeks of contract signing.
• The deployment was supported on‑site by two‑time Chemistry Nobel Laureate Prof. Barry Sharpless and highlights Telescope’s rapid‑deployment capability and growing commercial momentum in autonomous R&D.
• The installation positions Telescope and its Acceleration Consortium partners to expand SDL adoption across pharma, industrial chemistry, energy, and agriculture worldwide.

Key Details

• Project Scope: First pharmaceutical Self‑Driving Lab in South Korea, delivered to KPBMA’s new AI‑focused R&D training centre in Seoul.
• Timeline: Installation completed within three weeks of purchase finalization.
• Key Personnel on Site: Prof. Barry Sharpless (two‑time Nobel Laureate, Telescope Senior Scientific Advisor) and Jason Hein (CTO, Telescope; scientific leader at the Acceleration Consortium).
• Technology Highlights: Integrated robotics, inline analytics, and AI enabling closed‑loop autonomous experimentation; capable of running hundreds of experiments continuously with higher speed, precision, and cost efficiency.
• Strategic Partnerships: Collaboration facilitated by the Acceleration Consortium (AC), a network linking academia, industry, and government to accelerate SDL deployment.
• Commercial Implications: Demonstrates Telescope’s ability to deliver advanced autonomous R&D systems on aggressive timelines; expected to drive further sales in pharmaceutical research and open new markets in industrial chemistry, energy, and agriculture.
• Government & Academic Support: Initial Canadian government investments (2018, 2023) and University of British Columbia spin‑off origins contributed to technology development; participation in BC Premier’s trade mission to Korea reinforced bilateral relationships.
• Future Outlook: Telescope plans to leverage this milestone to expand commercial opportunities globally, targeting additional deployments across multiple sectors where Self‑Driving Labs can accelerate material and drug discovery.

Notable Quotes

“Our work in Seoul is a huge milestone toward making autonomous R&D a practical reality for pharmaceutical innovation.” – Jason Hein, CTO, Telescope Innovations

“AI is only as good as the chemistry it’s based on, and Telescope’s chemistry is superlative… It’s exciting to participate in making Self‑Driving Labs a reality.” – Prof. Barry Sharpless

“The sale of this self‑driving lab is emblematic of the strides we can make worldwide by bringing intelligent automation directly into the hands of researchers.” – Sean Caffrey, Executive Director, Acceleration Consortium